AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.3305
+0.0995 (43.07%)
Sep 10, 2026, 11:49 AM EDT - Market open
AEON Biopharma Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, AEON Biopharma stock has a consensus rating of "Strong Buy" and an average price target of $1.53. The average 1-year stock price forecast is 362.93% higher than the current stock price, while the lowest is $1.00 (+202.57%) and the highest is $2.10 (+535.40%).
Price Target: $1.53 (+362.93%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AEON Biopharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Laidlaw | Laidlaw | Buy Initiates $1.8 | Buy | Initiates | $1.8 | +444.63% | Sep 9, 2026 |
| Lake Street | Lake Street | Buy Maintains $1 | Buy | Maintains | $1 | +202.57% | Aug 19, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $5 → $1.2 | Buy | Maintains | $5 → $1.2 | +263.09% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
590.00K
EPS This Year
-0.46
from -3.95
EPS Next Year
-0.27
from -0.46
EPS and Forward PE are based on non-GAAP adjusted numbers.